David Bonita Biography and Net Worth

Director of ImageneBio

Dr. Bonita has served as a member of the Ikena board since March 2016. Dr. Bonita is a member of OrbiMed Advisors LLC, an investment firm. Dr. Bonita currently serves on the boards of directors of Acutus Medical Inc. (Nasdaq: AFIB), Prelude Therapeutics, Inc. (Nasdaq: PRLD), Repare and Third Harmonic Bio, Inc. (Nasdaq: THRD), as well as several private companies. Dr. Bonita also previously served on the board of directors of IMARA, Inc. (Nasdaq: IMRA) and Tricida, Inc. (Nasdaq: TCDA). Prior to OrbiMed, Dr. Bonita worked as a corporate finance analyst in the healthcare investment banking groups of Morgan Stanley and UBS. He received his B.A. in biology from Harvard University and his joint M.D./M.B.A. from Columbia University. We believe that Dr. Bonita is qualified to serve on the Ikena board based on his roles on several public and private boards of directors as well as his extensive experience in investing in healthcare companies.

What is David P. Bonita's net worth?: The estimated net worth of David P. Bonita is at least $57.49 million as of April 21st, 2026. Dr. Bonita owns 11,808,945 shares of ImageneBio stock worth more than $57,485,944 as of September 23rd. This net worth approximation does not reflect any other investments that Dr. Bonita may own. Learn More about David P. Bonita's net worth.
How do I contact David P. Bonita?: The corporate mailing address for Dr. Bonita and other ImageneBio executives is 12526 High Bluff Drive, San Diego, CA, 92130. ImageneBio can also be reached via phone at (857) 343-8292 and via email at [email protected]. Learn More on David P. Bonita's contact information.
Has David P. Bonita been buying or selling shares of ImageneBio?: David P. Bonita has not been actively trading shares of ImageneBio during the past quarter. Most recently, on Friday, July 25th, David P. Bonita bought 83,611 shares of ImageneBio stock. The stock was acquired at an average cost of $29.90 per share, with a total value of $2,499,968.90. Following the completion of the transaction, the director now directly owns 287,885 shares of the company's stock, valued at $8,607,761.50. Learn More on David P. Bonita's trading history.
Who are ImageneBio's active insiders?: ImageneBio's insider roster includes David Bonita (Director), Jean-Francois Formela (Director), and Michelle Zhang (Insider). Learn More on ImageneBio's active insiders.
Are insiders buying or selling shares of ImageneBio?: During the last year, ImageneBio insiders bought shares 1 times. They purchased a total of 16,000 shares worth more than $95,840.00. The most recent insider tranaction occured on December, 24th when Director Joseph P Slattery bought 16,000 shares worth more than $95,840.00. Insiders at ImageneBio own 2.2% of the company. Learn More about insider trades at ImageneBio.
Information on this page was last updated on 12/24/2025.

David P. Bonita Insider Trading History at ImageneBio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
7/25/2025	Buy	83,611	$29.90	$2,499,968.90	287,885

David P. Bonita Buying and Selling Activity at ImageneBio

ImageneBio Company Overview

ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. Its lead product includes IMG-007, a non-depleting anti-OX40 mAb that has completed Phase 2a clinical trials for the treatment of atopic dermatitis and alopecia areata. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

Today's Range

Now: $4.87

$4.81

$4.98

50 Day Range

MA: $5.42

$4.81

$6.01

2 Week Range

Now: $4.87

$3.94

$9.10

Volume

1,479 shs

Average Volume

134,705 shs

Market Capitalization

$55.25 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.7